Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bristol Myers Squibb : Assigned Patent

07/25/2014 | 07:18am US/Eastern

By Targeted News Service

ALEXANDRIA, Va., July 25 -- Bristol-Myers Squibb, Princeton, New Jersey, has been assigned a patent (8,785,398) developed by four co-inventors for the "methods of treatment using CTLA4 mutant molecules." The co-inventors are Robert James Peach, San Diego, Joseph Naemura, Bellevue, Washington, Peter S. Linsley, Seattle, and Jurgen Bajorath, Bonn, Germany.

The patent application was filed on Oct. 20, 2011 (13/277,425). The full-text of the patent can be found at,85,398.PN.&OS=PN/87,85,398&RS=PN/87,85,398

Written by Sudarshan Harpal; edited by Jaya Anand.


(c) 2014 Targeted News Service

React to this article
15h ago BRISTOL MYERS SQUIBB : Reports Outline Hepatitis C Virus and Genetics Study Resu..
19h ago BRISTOL MYERS SQUIBB : Studies from Bristol-Myers Squibb Update Current Data on ..
20h ago Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce Immun..
1d ago BRISTOL MYERS SQUIBB : to Announce Results for Fourth Quarter, Full Year 2014 on..
1d ago Ono Pharma, Bristol-Myers & Kyowa Hakko Kirin enter pact to condutct phase 1 ..
1d ago BRISTOL MYERS SQUIBB : Assigned Patent
2d agoDJMetLife, TRW Sign $440 Million Pension Buyout Agreement
6d agoDJDanone Committed to All Business Units -- 2nd Update
6d agoDJDanone Committed to All Business Units -- Update
7d ago Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce Immun..
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes